Pancreatic Cancer Research

ResearcherCapital Medical UniversityActive in the last 2 years

Xiangyu Chu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5121599113. Sources: OpenAlex.

Their work

Papers
4 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2025: 2 papers · 2026: 2 papers

Papers 4

  1. Exosomal miR-4644 Targets SPRY3 to Promote Proliferation and Invasion of Pancreatic Cancer. Co-author DOI 10.1002/cam4.72000↗
  2. The Acidic Exosomal miR-1246/WASF3 Axis Regulates Hepatic Stellate Cell Activation and Stiff ECM Remodeling to Promote Pancreatic Ductal Adenocarcinoma Liver M… First author DOI 10.7150/ijbs.132772↗
  3. Tumor-derived exosomes: Unravelling the pathogenesis of pancreatic cancer with liver metastases and exploring the potential for clinical translation. First author DOI 10.1016/j.canlet.2024.217403↗
  4. Targeted degradation of Pin1 by an antagonistic peptide enhances gemcitabine therapy in pancreatic cancer. First author DOI 10.1039/d5md00970g↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yinmo Yang · 3 shared papers, 2025–2026 · strength 0.86
  2. Yongsu Ma · 2 shared papers, 2025–2026 · strength 0.58
  3. Dongqi Li · 2 shared papers, 2026 · strength 0.58
  4. Xiaodong Tian · 1 shared paper, 2026 · strength 0.30
  5. Dongqi Li · 1 shared paper, 2025 · strength 0.28
  6. Xiaodong Tian · 1 shared paper, 2025 · strength 0.28
  7. Xiaodong Tian · 1 shared paper, 2026 · strength 0.28
  8. Chen Wang · 1 shared paper, 2025 · strength 0.26
  9. Mengting Chen · 1 shared paper, 2025 · strength 0.26

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.